866-997-4948(US-Canada Toll Free)

Investigation Report on China Thymosin a1 Market, 2010-2019

Published By :

China Research and Intelligence Co., Ltd. (CRI)

Published Date : Jun 2015

Category :

Manufacturing, Packaging & Detailing

No. of Pages : 30 Pages

Thymosin products which can enhance body immunity are mainly used in the treatment of hepatitis and tumor and can be categorized into thymosin (extracted), thymopentin and thymosin α1, a high-end product.

First developed by SciClone Pharmaceuticals, Inc., thymosin α1’s being used for tumor immunotherapy as immunomodulator has increasingly gained people’s attention. In the clinic, it has been used for the treatment of many kinds of tumors like non-small cell lung cancer, malignant melanoma, liver cancer, non-Hodgkin lymphomia and so on. Research has shown that thymosin α1 can enhance patients’ immunity, reduce side effects and infection rate, improve life quality and raise remission rate or even survival rate in the chemotherapy for tumors. As a vaccine adjuvant, thymosin α1 can boost the immune response to viral vaccines like influenza vaccine and hepatitis B vaccine in patients whose immune systems are comprised or inhibited, patients with chronic hemodialysis or senile diseases included.

Thymosin α1 develops fast after entering China, annual sales value rising from less than CNY 7 million in 2005 to CNY 968 million in 2014 and CAGR reaching up to 73.7%. currently, thymosin α1 in the Chinese market mainly come from Diao Group, Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd and Hainan Shuangcheng Pharmaceuticals Co., Ltd, among which Diao Group has the largest market share of about 36% for sales volume in 2014. However, Patheon Italia has the largest market share of nearly 50% for sales volume in 2014.

In the next few years, the market size of immunomodulator will grow gradually, so does that of thymosin α1.

Readers can get at least the following information from this report:
  • market size of thymosin α1 in China
  • competitive landscape of thymosin α1 in Chinese market
  • price of thymosin α1 made by different enterprises in China
  • market outlook of thymosin α1 in China
The author suggests the following groups of people purchase this report:
  • manufacturers of immunomodulator
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service
Table of Content

1 Related Concepts of Thymosin α1
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Thymosin α1 in China
2.1 Patent and Approval Status of Thymosin α1 in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Thymosin α1 in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Thymosin α1 in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Thymosin α1 in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Thymosin α1 in Chinese Hospitals in 2014
6.1 Patheon Italia S.p.A. (IT) (Trade Name: Zadaxin)
6.2 Shanghai No.1 Biochemical Pharmaceutical Co., Ltd
6.3 Harbin Pharmaceutical Group Bioengineering Co., Ltd
6.4 Diao Group (Trade Name: Maipuxin)
6.5 Hainan Zhonghe Pharmaceutical Co., Ltd (Trade Name: Heri)
6.6 Hainan Shuangcheng Pharmaceuticals Co., Ltd (Trade Name: Jitai)
6.7 Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd

7 Major Manufacturers of Thymosin α1 in Chinese Market, 2010-2014
7.1 Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd
7.2 Hainan Shuangcheng Pharmaceuticals Co., Ltd
7.3 Hainan Zhonghe Pharmaceutical Co., Ltd
7.4 Diao Group
7.5 Shanghai No.1 Biochemical Pharmaceutical Co., Ltd
7.6 Patheon Italia S.p.A.

8 Market Outlook of Thymosin α1 in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Chart


Chart Registration Information of Related Medicines of Thymosin α1
Chart Sales Status of Thymosin α1 in China, 2010-2014
Chart Sales Value of Thymosin α1 in China, 2010-2014
Chart Sales Value of Thymosin α1 in Some Regions in China, 2010-2014
Chart Sales Volume of Thymosin α1 in China, 2010-2014
Chart Market Share of TOP5 Manufacturers of Thymosin α1 for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Thymosin α1 Made by Patheon Italia(IT) in China, 2010-2014
Chart Sales Value and Market Share of Thymosin α1 Made by Diao in China, 2010-2014
Chart Sales Value and Market Share of Thymosin α1 Made by Hainan Shuangcheng in China, 2010-2014
Chart Sales Value and Market Share of Thymosin α1 Made by Hainan Zhonghe in China, 2010-2014
Chart Sales Value and Market Share of Thymosin α1 Made by Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical in China, 2010-2014
Chart Price of Thymosin α1 Made by Patheon Italia S.p.A. (IT) in Some Chinese Cities in 2014
Chart Price of Thymosin α1 Made by Shanghai No.1 Biochemical Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Thymosin α1 Made by Harbin Pharmaceutical Group Bioengineering Co., Ltd in Some Chinese Cities in 2014
Chart Price of Thymosin α1 Made by Diao Group in Some Chinese Cities in 2014
Chart Price of Thymosin α1 Made by Hainan Zhonghe Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Thymosin α1 Made by Hainan Shuangcheng Pharmaceuticals Co., Ltd in Some Chinese Cities in 2014
Chart Price of Thymosin α1 Made by Suzhou Tianma Pharma Group Tianji BIO-pharmaceutical Co., Ltd in Some Chinese Cities in 2014

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *